Distribution of topical medication in the human vagina as imaged by magnetic resonance imaging
- 1 July 2001
- journal article
- Published by Elsevier in Fertility and Sterility
- Vol. 76 (1) , 189-195
- https://doi.org/10.1016/s0015-0282(01)01822-2
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Duration of vaginal retention and potential duration of antiviral activity for five nonoxynol-9 containing intravaginal contraceptivesInternational Journal of Gynecology & Obstetrics, 1999
- Localization of Simian immunodeficiency virus-infected cells in the genital tract of male and female Rhesus macaquesJournal of Reproductive Immunology, 1998
- A Controlled Trial of Nonoxynol 9 Film to Reduce Male-to-Female Transmission of Sexually Transmitted DiseasesNew England Journal of Medicine, 1998
- Do Spermicides Containing Nonoxynol-9 Prevent Sexually Transmitted Infections?Sexually Transmitted Diseases, 1998
- High-resolution MR imaging of the vagina.RadioGraphics, 1997
- Quantitation of vaginally administered nonoxynol-9 in premenopausal womenContraception, 1997
- Spreading and retention of vaginal formulations in post-menopausal women as assessed by gamma scintigraphy.Pharmaceutical Research, 1997
- Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques.The Journal of Experimental Medicine, 1996
- Use of nonoxynol-9 and reduction in rate of gonococcal and chlamydial cervical infectionsThe Lancet, 1992
- A Clinical Trial of Nonoxynol-9 for Preventing Gonococcal and Chlamydial InfectionsThe Journal of Infectious Diseases, 1988